Turbine to develop its AI platform following $20 million in Series A funding
Turbine, a company developing a cell simulation platform, has raised $20m in a Series A financing round and will use the funding to develop its… read more
Turbine, a company developing a cell simulation platform, has raised $20m in a Series A financing round and will use the funding to develop its… read more
Article in Hungarian. read more
Article in Hungarian. read more
Biotech entrepreneur Mark Velleca is Board Chair, seasoned cancer biology advisors Gordon Mills and Klaus Hoeflich join Scientific Advisory Board. read more
Merck & Co's strategic investment fund was revealed as a co-lead investor. read more
Article in Hungarian. read more